Smith Anglin Financial’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $644K | Buy |
|
|||||
|
2025
Q1 | $719K | Sell |
|
|||||
|
2024
Q4 | $707K | Buy |
|
|||||
|
2024
Q3 | $746K | Buy |
|
|||||
|
2024
Q2 | $607K | Buy |
|
|||||
|
2024
Q1 | $643K | Buy |
|
|||||
|
2023
Q4 | $508K | Buy |
|
|||||
|
2023
Q3 | $481K | Buy |
|
|||||
|
2023
Q2 | $431K | Buy |
|
|||||
|
2023
Q1 | $504K | Buy |
|
|||||
|
2022
Q4 | $492K | Sell |
|
|||||
|
2022
Q3 | $418K | Buy |
|
|||||
|
2022
Q2 | $473K | Sell |
|
|||||
|
2022
Q1 | $535K | Sell |
|
|||||
|
2021
Q4 | $447K | Buy |
|
|||||
|
2021
Q3 | $333K | Sell |
|
|||||
|
2021
Q2 | $376K | Buy |
|
|||||
|
2021
Q1 | $357K | Sell |
|
|||||
|
2020
Q4 | $358K | Buy |
|